Sánchez-Quesada JL - Search Results

1

The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity.

Miñambres I, Sánchez-Hernández J, Sánchez-Quesada JL, Rodríguez J, de Leiva A, Pérez A. Miñambres I, et al. ISRN Endocrinol. 2012;2012:691803. doi: 10.5402/2012/691803. Epub 2012 Oct 24. ISRN Endocrinol. 2012. PMID: 23150833 Free PMC article.

2

Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control.

Sánchez-Quesada JL, Pérez A, Caixàs A, Ordónmez-Llanos J, Carreras G, Payés A, González-Sastre F, de Leiva A. Sánchez-Quesada JL, et al. Diabetologia. 1996 Dec;39(12):1469-76. doi: 10.1007/s001250050600. Diabetologia. 1996. PMID: 8960828

3

Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients.

Rigla M, Sánchez-Quesada JL, Ordóñez-Llanos J, Prat T, Caixàs A, Jorba O, Serra JR, de Leiva A, Pérez A. Rigla M, et al. Metabolism. 2000 May;49(5):640-7. doi: 10.1016/s0026-0495(00)80041-4. Metabolism. 2000. PMID: 10831176

4

Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A. Pérez A, et al. Arch Intern Med. 2000 Oct 9;160(18):2756-62. doi: 10.1001/archinte.160.18.2756. Arch Intern Med. 2000. PMID: 11025785

5

Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions.

Wägner AM, Sánchez-Quesada JL, Pérez A, Rigla M, Cortés M, Blanco-Vaca F, Ordóñez-Llanos J. Wägner AM, et al. Clin Chem. 2000 Nov;46(11):1830-2. Clin Chem. 2000. PMID: 11067819 No abstract available.

6

Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.

Sánchez-Quesada JL, Pérez A, Caixàs A, Rigla M, Payés A, Benítez S, Ordóñez-Llanos J. Sánchez-Quesada JL, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):3243-9. doi: 10.1210/jcem.86.7.7692. J Clin Endocrinol Metab. 2001. PMID: 11443196

7

Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients.

Wägner AM, Ordóñez-Llanos J, Hernández M, Sánchez-Quesada JL, Blanco-Vaca F, Rigla M, de Leiva A, Pérez A. Wägner AM, et al. Eur J Intern Med. 2001 Dec;12(6):496-502. doi: 10.1016/s0953-6205(01)00178-9. Eur J Intern Med. 2001. PMID: 11711272

8

Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion.

Wägner AM, Ordóñez-Llanos J, Arcelus R, Bonet R, Jorba O, Sánchez-Quesada JL, Alonso E, Julve J, Pérez A. Wägner AM, et al. Metabolism. 2003 Aug;52(8):1038-42. doi: 10.1016/s0026-0495(03)00090-8. Metabolism. 2003. PMID: 12898470 Clinical Trial.

9

Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes.

Wägner AM, Pérez A, Sánchez-Quesada JL, Ordóñez-Llanos J. Wägner AM, et al. Diabetes Care. 2005 Jul;28(7):1798-800. doi: 10.2337/diacare.28.7.1798. Diabetes Care. 2005. PMID: 15983340 No abstract available.

10

The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

Sánchez-Quesada JL, Benítez S, Pérez A, Wagner AM, Rigla M, Carreras G, Vila L, Camacho M, Arcelus R, Ordóñez-Llanos J. Sánchez-Quesada JL, et al. Diabetologia. 2005 Oct;48(10):2162-9. doi: 10.1007/s00125-005-1899-8. Epub 2005 Aug 18. Diabetologia. 2005. PMID: 16132957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters